Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes
- 1 July 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 336 (8706) , 32-34
- https://doi.org/10.1016/0140-6736(90)91531-e
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Peripheral pharmacokinetics of apomorphine in humansAnnals of Neurology, 1989
- Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Multiple system atrophy--the nature of the beast.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- SUBCUTANEOUS APOMORPHINE AS A DIAGNOSTIC TEST FOR DOPAMINERGIC RESPONSIVENESS IN PARKINSONIAN SYNDROMESThe Lancet, 1989
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Response to brief levodopa infusions in parkinsonian patients with and without motor fluctuationsNeurology, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONSThe Lancet, 1988
- The clinical features and natural history of the Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)Neurology, 1986
- Progressive supranuclear palsy: Clinical features and response to treatment in 16 patientsAnnals of Neurology, 1983